- Home
- ROKU vs ASND Comparison
ROKU vs ASND Comparison
Compare ROKU & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROKU
- ASND
- Stock Information
- Founded
- ROKU 2002
- ASND 2006
- Country
- ROKU United States
- ASND Denmark
- Employees
- ROKU N/A
- ASND N/A
- Industry
- ROKU Cable & Other Pay Television Services
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- ROKU Telecommunications
- ASND Health Care
- Exchange
- ROKU Nasdaq
- ASND Nasdaq
- Market Cap
- ROKU 12.5B
- ASND 10.6B
- IPO Year
- ROKU 2017
- ASND 2015
- Fundamental
- Price
- ROKU $90.29
- ASND $198.32
- Analyst Decision
- ROKU Buy
- ASND Strong Buy
- Analyst Count
- ROKU 25
- ASND 16
- Target Price
- ROKU $98.24
- ASND $239.50
- AVG Volume (30 Days)
- ROKU 4.7M
- ASND 549.0K
- Earning Date
- ROKU 07-31-2025
- ASND 08-07-2025
- Dividend Yield
- ROKU N/A
- ASND N/A
- EPS Growth
- ROKU N/A
- ASND N/A
- EPS
- ROKU N/A
- ASND N/A
- Revenue
- ROKU $4,394,960,000.00
- ASND $576,332,355.00
- Revenue This Year
- ROKU $12.69
- ASND $79.35
- Revenue Next Year
- ROKU $12.25
- ASND $76.18
- P/E Ratio
- ROKU N/A
- ASND N/A
- Revenue Growth
- ROKU 17.32
- ASND 54.50
- 52 Week Low
- ROKU $52.43
- ASND $111.09
- 52 Week High
- ROKU $104.96
- ASND $199.99
- Technical
- Relative Strength Index (RSI)
- ROKU 56.16
- ASND 69.11
- Support Level
- ROKU $81.18
- ASND $187.24
- Resistance Level
- ROKU $86.64
- ASND $197.67
- Average True Range (ATR)
- ROKU 3.61
- ASND 8.86
- MACD
- ROKU -0.04
- ASND 1.92
- Stochastic Oscillator
- ROKU 69.60
- ASND 95.73
About ROKU Roku Inc.
Roku enables consumers to stream television programming. It has more than 90 million streaming households and provided 127 billion streaming hours in 2024. Roku is the top streaming operating system in the US, reaching more than half of broadband households, according to the company. Roku's OS is built into streaming devices and televisions that Roku sells and on connected televisions from other manufacturers that license Roku's name and software. Roku also operates the Roku Channel, a free, ad-supported streaming television platform that offers a mix of on-demand and live television programming. Roku generates revenue primarily from selling devices, licensing, and advertising, and it receives fees from subscription streaming platforms that sell subscriptions through Roku.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.